Home | Breaking Out | AI powered stock trade ideas | Bullish Engulfing | Market Signals | New Green Signal Stocks | Recent Red Arrow Top Signals | Recent Green Arrow Bottom Signals | Near Term Bottom Signals | Green Stocks with Most Upside to Analyst Target Price | New Long Term Green AI Signals | Big Tech Stocks | ETF Sector SPDRs | Solar Stocks | Chip Stocks | Airline Stocks | Social Media Stocks | Oil Stocks| Discount Store Stocks | Entertainment Stocks | EV Stocks | Restaurant Stocks | Heavy Equipment Stocks | Aerospace Stocks | Home Builders | Bank Stock Signals | Cruise Ship Stock Signals | Mining Stocks | Free AI Portfolio Analyzer | How to Read and Trade AI Powered Stock Charts| Stock Charts AI top 50 Stocks

AI Options Trading Bot (BETA)
Enter Stock Symbol to View AI powered Stock Chart

StockChartsAI.com

All Chart Prices Delayed at least 15 minutes

Before accessing this site, you agree that you have read and agree to the disclaimers at the bottom of this page.


Stock Charts AI Power Rank: 0.5
Power Rank trend -> Rising

Last Price: 179.36 - Change: -0.66 - Change %: -0.3666
03/27/2025 16:10:00 EST

IQVIA Holdings Inc (IQV)

Industry: Diagnostics & Research

Price Support Resistance

In the past 20 trading days, IQV has been trading in a range between $191.63 and $181.43 (gray range band). Red lines on the chart represent key resistance levels and Green lines represent key support levels. As the price moves above the lines you will notice they turn green and red if price moves below a line.

The AI powered stock chart is in a Red zone currently. We would avoid this stock.

Upside / Downside Potential

IQVIA Holdings Inc $IQV entered a Red zone 1 days ago on the AI powered stock chart. Wall Street analysts have an AVG target price $249.5367, a potential upside of 38.62% from the recent price of 180.02. The stock is trading 41.01% (potential upside) below its 52 week high of $253.84 and 0.41 % (potential downside) above its 52 week low of $179.28 - based on the recent price.

Company Summary

IQVIA Holdings Inc provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

IQV Website

News

Here's Why Investors Must Hold IQV Stock in Their Portfolios Now
The IQV stock is benefiting from partner retention, acquisition and investment in AI-led innovation.
Source: Zacks Investment Research
Wed, 26 Mar 2025 11:55:31 -0400
Sentiment: Positive
IQVIA recognized as a leader in IDC MarketScape's 2024 assessment for decentralized clinical trial technologies and consulting services
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of AI-powered analytics, technology solutions and clinical research services to the healthcare and life sciences industries, has been named to the “Leaders” category of the IDC MarketScape: Worldwide Life Science R&D Decentralized Clinical Trial Technology Solutions and Consulting Services 2024 Vendor Assessment. IDC, a global provider of market intelligence, says in its report: “Consider IQVIA when s.
Source: Business Wire
Mon, 10 Mar 2025 09:00:00 -0400
Sentiment: Neutral
IQVIA Gains From Diversified Client Base Despite Low Liquidity Woes
The IQV stock benefits from its healthcare-centric IT infrastructure across the globe and a treasure trove of data distinguishing it from its competitors.
Source: Zacks Investment Research
Fri, 07 Mar 2025 12:36:09 -0500
Sentiment: Positive
IQVIA Laboratories launches Site Lab Navigator with breakthrough e-Requisition innovation to transform clinical trials
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Laboratories, a leading global drug discovery and development laboratory services organization, announces the launch of Site Lab Navigator, an advanced suite of solutions that automates and streamlines lab workflows for clinical trial sponsors and investigator sites. At the core of Site Lab Navigator is a new, innovative e-Requisition solution, which allows investigator sites to submit requisitions and manage lab specimens electronically, eli.
Source: Business Wire
Tue, 04 Mar 2025 09:00:00 -0500
Sentiment: Neutral
Global Healthy Living Foundation and IQVIA Institute Report Millions of Adult Vaccines Likely Missed When States Restrict Pharmacist Participation
UPPER NYACK, N.Y.--(BUSINESS WIRE)--When pharmacists can't give adult vaccinations, millions of people go without them.
Source: Business Wire
Tue, 25 Feb 2025 15:00:00 -0500
Sentiment: Neutral
Instituions Institution %: 95.89
Last QTR Institution change: -409286

Insiders
Insiders %: 0.877
Insiders Purchases last QTR: 1275
Insiders Sales last QTR: 1300
Insiders Net last QTR: -25

Analyst Ratings
Target Price: 249.5367
Overall Rating: 4.4231
Strong Buys (5): 15
Buys (4): 7
Holds (3): 4
Sells (2): 0
Strong Sells (1): 0

Technicals
52 Week Hi: 253.84
52 Week Low: 176.7401
Beta: 1.506
50 Day MA: 194.0084
200 Day MA: 214.6151

Earnings / Revenue Trends
Qtr Earnings Growth YOY: -0.048
Qtr Revenue Growth YOY: 0.023
Forward PE: 15.083
Trailing PE: 24.0429

Benefits of StockChartsAI.com System:

  • Get a Daily List of Stocks Starting New Trends
  • Upload Your Stocks to Quickly See and Track Signals
  • Easy to Understand AI Stock Signals
  • Analysis of Historical Signal Trend Analysis for each stock
  • Search/View AI Stock Signals of Russel 1000 Stocks
  • Easy to Understand AI Stock Signals
  • And MUCH MUCH more!

1000

Stock Analyzed Each Night

Portfolio

Easily Upload Track Your Stocks

Trends

See Lists of Stocks Starting New Trends

The information contained on this website is solely for educational purposes, and does not constitute investment advice. The risk of trading in securities markets can be substantial. By accessing this site, you agree we are not liable, whether in contract, tort (including negligence) or otherwise, in respect of any damage, expense or other loss you may suffer arising out of such information or any reliance you may place upon such information from this site. Stocks, Futures and options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stock, futures and options markets. Don't trade with money you can't afford to lose. This website is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this website. The past performance of any trading system or methodology is not necessarily indicative of future results. Individual results may vary, and testimonials are not claimed to represent typical results. All testimonials are by real people, and may not reflect the typical purchaser’s experience, and are not intended to represent or guarantee that anyone will achieve the same or similar results. HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY, SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.